A Clinical Trial Via Telepsychiatry of Treatments for the Management of Emotional Dysregulation in Youth

Exclusion Criteria

• •Investigator and his/her immediate family; defined as the investigator's spouse, parent, child, grandparent, or grandchild.
• •Serious or unstable illness including hepatic, renal, gastroenterological, respiratory, cardiovascular (including ischemic heart disease), endocrinologic, neurologic, immunologic, or hematologic disease.
• •History of bleeding diathesis, including those with von Willebrand disease.
• •Uncorrected hypothyroidism or hyperthyroidism.
• •History of sensitivity to omega-3 fatty acids, inositol or NAC. A non-responder or history of intolerance to omega-3 fatty acid, inositol or NAC after 2 months of treatment at adequate doses as determined by the clinician.
• •Severe allergies or multiple adverse drug reactions.
• •Unstable or untreated seizure disorder.
• •DSM-IV substance use, abuse or dependence.
• •Judged clinically to be at serious suicidal risk or C-SSRS score ≥ 4.
• •Current diagnosis of schizophrenia.
• •Current diagnosis or symptoms of psychosis.
• •IQ \< 70.
• •Pregnant or nursing.